Company Filing History:
Years Active: 1999
Title: Innovations of John W Funder
Introduction
John W Funder is a notable inventor based in North Carlton, Australia. He has made significant contributions to the field of medical research, particularly in the area of glucocorticoid dehydrogenases. With a total of two patents to his name, Funder's work has the potential to impact various medical applications.
Latest Patents
Funder's latest patents focus on genetic sequences encoding glucocorticoid dehydrogenases and their uses. The first patent describes a nucleic acid molecule encoding a recombinant NAD+ dependent glucocorticoid dehydrogenase, specifically 11 .beta.-hydroxysteroid dehydrogenase-2 (11 .beta.HSD2). This invention is utilized to assay for potential agonists or antagonists of glucocorticoid dehydrogenase activity when expressed in prokaryotic or eukaryotic cells. Additionally, it relates to immunoreactive molecules that serve as diagnostic agents for conditions such as hypertension and in predicting outcomes of in vitro fertilization and embryo transfer procedures.
Career Highlights
Funder is currently affiliated with the Baker Medical Research Institute, where he continues to advance his research. His work has garnered attention for its innovative approach to understanding glucocorticoid metabolism and its implications for health.
Collaborations
Some of Funder's notable coworkers include Anthony L Albiston and Varuni R Obeyesekere. Their collaborative efforts contribute to the ongoing research and development in the field of glucocorticoid dehydrogenases.
Conclusion
John W Funder's contributions to medical research through his patents on glucocorticoid dehydrogenases highlight his innovative spirit and dedication to advancing healthcare solutions. His work continues to pave the way for new diagnostic and therapeutic approaches.